Risk factors for post-coronavirus disease condition in the Alpha-, Delta-, and Omicron-dominant waves among adults in Japan: A population-based matched case-control study

IF 6.8 3区 医学 Q1 VIROLOGY Journal of Medical Virology Pub Date : 2024-09-23 DOI:10.1002/jmv.29928
Miyuki Hori, Mina Hayama-Terada, Akihiko Kitamura, Mariko Hosozawa, Yoko Muto, Arisa Iba, Yoshihiro Takayama, Takashi Kimura, Hiroyasu Iso
{"title":"Risk factors for post-coronavirus disease condition in the Alpha-, Delta-, and Omicron-dominant waves among adults in Japan: A population-based matched case-control study","authors":"Miyuki Hori,&nbsp;Mina Hayama-Terada,&nbsp;Akihiko Kitamura,&nbsp;Mariko Hosozawa,&nbsp;Yoko Muto,&nbsp;Arisa Iba,&nbsp;Yoshihiro Takayama,&nbsp;Takashi Kimura,&nbsp;Hiroyasu Iso","doi":"10.1002/jmv.29928","DOIUrl":null,"url":null,"abstract":"<p>Vaccination is associated with a reduced risk of post-coronavirus disease (COVID-19) condition (PCC). Here, risk factors including vaccination for PCC in the Omicron-dominant waves among Japanese adults were investigated. This was a registry-based matched case-control study of individuals aged 18–79 years diagnosed with COVID-19 registered in a National database between March 2021 and April 2022 and matched noninfected individuals living in Yao City, Japan. A self-administered questionnaire was used to assess persistent symptoms and their risk factors. The COVID-19 vaccination status was obtained from the Vaccination Registry. PCC risk factors were analyzed using logistic regression after adjusting for potential confounding factors. Overall, 4185 infected (cases) and 3382 noninfected (controls) individuals were included in the analysis. The mean ages and proportions of women were 44.7 years and 60.2% and 45.5 years and 60.7% for cases and controls, respectively. A total of 3805 (90.9%) participants had asymptomatic or mild acute symptoms at the median (range) follow-up of 271 (185–605) days. The prevalence of PCC was 15.0% for cases while that of persistent symptoms was 4.4% for controls; among the cases, it was 27.0% in the Alpha- and Delta-dominant waves and 12.8% in the Omicron-dominant wave. Female sex, comorbidities, and hospitalization were positively associated with PCC. One or more vaccine doses of vaccination were inversely associated with PCC; the inverse association was stronger in the Alpha- and Delta-dominant waves (adjusted odds ratio [aOR]: 0.29, 95% confidence interval [CI]: 0.12–0.73) than in the Omicron-dominant wave (aOR: 0.79, 95% CI: 0.59–1.07).</p>","PeriodicalId":16354,"journal":{"name":"Journal of Medical Virology","volume":"96 9","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Virology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jmv.29928","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Vaccination is associated with a reduced risk of post-coronavirus disease (COVID-19) condition (PCC). Here, risk factors including vaccination for PCC in the Omicron-dominant waves among Japanese adults were investigated. This was a registry-based matched case-control study of individuals aged 18–79 years diagnosed with COVID-19 registered in a National database between March 2021 and April 2022 and matched noninfected individuals living in Yao City, Japan. A self-administered questionnaire was used to assess persistent symptoms and their risk factors. The COVID-19 vaccination status was obtained from the Vaccination Registry. PCC risk factors were analyzed using logistic regression after adjusting for potential confounding factors. Overall, 4185 infected (cases) and 3382 noninfected (controls) individuals were included in the analysis. The mean ages and proportions of women were 44.7 years and 60.2% and 45.5 years and 60.7% for cases and controls, respectively. A total of 3805 (90.9%) participants had asymptomatic or mild acute symptoms at the median (range) follow-up of 271 (185–605) days. The prevalence of PCC was 15.0% for cases while that of persistent symptoms was 4.4% for controls; among the cases, it was 27.0% in the Alpha- and Delta-dominant waves and 12.8% in the Omicron-dominant wave. Female sex, comorbidities, and hospitalization were positively associated with PCC. One or more vaccine doses of vaccination were inversely associated with PCC; the inverse association was stronger in the Alpha- and Delta-dominant waves (adjusted odds ratio [aOR]: 0.29, 95% confidence interval [CI]: 0.12–0.73) than in the Omicron-dominant wave (aOR: 0.79, 95% CI: 0.59–1.07).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
日本成人中阿尔法波、德尔塔波和奥米克隆波主导的冠状病毒后疾病状况的风险因素:基于人群的匹配病例对照研究。
接种疫苗与降低冠状病毒病(COVID-19)后病情(PCC)的风险有关。在此,研究人员调查了日本成年人中包括接种 PCC 疫苗在内的风险因素。这是一项基于登记的匹配病例对照研究,研究对象是 2021 年 3 月至 2022 年 4 月期间在国家数据库中登记的 18-79 岁确诊 COVID-19 感染者和居住在日本八尾市的匹配非感染者。研究采用自填问卷的方式评估持续性症状及其风险因素。COVID-19疫苗接种情况从疫苗接种登记处获得。在调整了潜在的混杂因素后,使用逻辑回归分析了 PCC 风险因素。共有 4185 名感染者(病例)和 3382 名非感染者(对照组)参与了分析。病例和对照组的平均年龄和女性比例分别为 44.7 岁和 60.2%,45.5 岁和 60.7%。共有 3805 人(90.9%)在中位数(范围)为 271 天(185-605 天)的随访中出现无症状或轻微急性症状。病例的 PCC 患病率为 15.0%,而对照组的持续症状患病率为 4.4%;在病例中,阿尔法和德尔塔主导波的 PCC 患病率为 27.0%,而奥米克主导波的 PCC 患病率为 12.8%。女性性别、合并症和住院治疗与 PCC 呈正相关。接种一剂或多剂疫苗与 PCC 呈反向关系;与 Omicron 主导波(aOR:0.79,95% 置信区间:0.59-1.07)相比,Alpha 和 Delta 主导波的反向关系更强(调整后的几率比 [aOR]:0.29,95% 置信区间 [CI]:0.12-0.73)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Medical Virology
Journal of Medical Virology 医学-病毒学
CiteScore
23.20
自引率
2.40%
发文量
777
审稿时长
1 months
期刊介绍: The Journal of Medical Virology focuses on publishing original scientific papers on both basic and applied research related to viruses that affect humans. The journal publishes reports covering a wide range of topics, including the characterization, diagnosis, epidemiology, immunology, and pathogenesis of human virus infections. It also includes studies on virus morphology, genetics, replication, and interactions with host cells. The intended readership of the journal includes virologists, microbiologists, immunologists, infectious disease specialists, diagnostic laboratory technologists, epidemiologists, hematologists, and cell biologists. The Journal of Medical Virology is indexed and abstracted in various databases, including Abstracts in Anthropology (Sage), CABI, AgBiotech News & Information, National Agricultural Library, Biological Abstracts, Embase, Global Health, Web of Science, Veterinary Bulletin, and others.
期刊最新文献
Concerns on a New Varicella Vaccine Introduced in Korea Molecular Analysis of Coxsackievirus B2 Associated With Severe Symptoms of the Central Nervous System Rhinovirus in pediatric respiratory infections: More than a simple cold Epidemiological Characteristics of Neuro-Specific Antibodies Following Viral Infections Identifying Gaps in Congenital CMV Detection—Implications for the Recent European Consensus Guidelines on Congenital CMV Infection
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1